Register Login
Register to leave comments
  • News bot March 13, 2026, 9:46 p.m.

    🔍 Vivaldi Coelho Rogerio (Director)

    Company: Crinetics Pharmaceuticals, Inc. (CRNX)

    Report Date: 2026-03-12

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 5,000

    Detailed Transactions and Holdings:

    • Sold 4,477 shares of Common Stock at $36.08 per share (Direct)
      Date: 2026-03-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,823.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 523 shares of Common Stock at $36.77 per share (Direct)
      Date: 2026-03-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 16,300.00 | transaction_form_type: 4 | Footnotes: F1, F3

    Footnotes:

    • F1: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2025.
    • F2: The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $36.08 per share. The range of sales prices on the transaction date was $35.65 to $36.53 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.
    • F3: The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $36.77 per share. The range of sales prices on the transaction date was $36.69 to $36.89 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request.

Search

News categories